Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry

BACKGROUND: The objectives of this study were to describe the profile of ankylosing spondylitis (AS) patients treated with either infliximab (IFX) or subcutaneous golimumab (GLM) treatment in Canadian routine care setting along with assessing long-term effectiveness and safety. METHODS: AS patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Proton, Starr, Michael, Haaland, Derek, Bessette, Louis, Teo, Michelle, Rampakakis, Emmanouil, Lehman, Allen J., Nantel, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666769/
https://www.ncbi.nlm.nih.gov/pubmed/33292797
http://dx.doi.org/10.1186/s41927-020-00158-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666769/
https://www.ncbi.nlm.nih.gov/pubmed/33292797
http://dx.doi.org/10.1186/s41927-020-00158-z

Ejemplares similares